Research Article

Seroprevalence of Hepatitis B surface antigen (HBsAg) and: Hepatitis C virus (HCV) co-infection among Apparently Healthy Students of a Tertiary Institution in North-eastern Nigeria

Musa Yakubu Tula1*, Iyoha, O.2, Okpalauwaekwe, E.A.3, Mohammed, A.3, Iruolaje, P.O.4, Okpara, A,N.3
1 Department of Biomedical Science Technology, Federal Polytechnic Mubi, Adamawa State, Nigeria.
2 Department of Medical Microbiology, School of Medicine, College of Medical Science University of Benin, P.M.B. 1152, Benin City, Nigeria.
3 Department of Biological Science Technology, Federal Polytechnic Mubi, Adamawa State, Nigeria.
4 Department of Science Laboratory Technology, Federal Polytechnic Bauchi, Nigeria
* Corresponding author: birtyty@gmail.com
Published: Jun, 2018
DOI: 10.67614/njm.2018.g284hwi9
Pages: 4290-4296

Abstract

This is a cross-sectional laboratory based study in which two hundred blood samples were aseptically and randomly collected from apparently healthy students of Federal Polytechnic Mubi. Participants were screened for Hepatitis B surface antigen and anti HCV antibody using standard procedures. Ethical clearance and participant's informed consent were sought and obtained from appropriate authorities and concerned participants respectively. All data generated from this study were analysed for statistical relevance using Mann-Whitney and Duncan Chi square test. Of the 200 samples screened, 20% were seropositive for HBsAg while 11.5% were seropositive for anti-HCV antibody. The sex related prevalence of 22.1% formales and 15.9% forfemales were obtained for HBV, while 13.7% for males and 7.2% for females were obtained for HCV. There was no significant association between gender and HBsAg (P=0.281) and HCV (P=0.196) infections. All the age brackets showed no HBsAg/HCV co-infection. While HBsAg was found to be more prevalent among age group 25-29yrs (32.8%), HCV was found to be more prevalent among the age group 30-34yrs (20.6%) but with no statistical difference for both HBsAg (P=0.135) and HCV (P=0.199).

Keywords

Seroprevalence Hepatitis Apparently healthy Co-infection

References

  1. Adebayo, A.A. (2004). Mubi Region. A Geographic Synthesis; Paraclete Publishers, Yola. pp. 17 – 37.
  2. Adekeye, A.M., Chukwuedo, A.A., Zakcam, P.N. and Yakubu, R.S. (2013). Prevalence of Hepatitis B and C among Blood Donors in Jos South LGA Plateau State, Nigeria. Asian J. Med. Sci. 5(5): 101-104.
  3. Adeoule, O.O., Andeyi, E., Ajuwon, Z. and Wada, I. (2009). Sero-prevalence of hepatitis B and C viruses co-infection in Nigeria patients with HIV infection. J. Infect. Dev. Ctries. 6(5): 369-375.
  4. Adiga, M.P, Gyar, S.D. Pechuluno, S., Bashayi, O.D., Enisasgen, S.E., Zungwe, T., Iperepolo, O.H. Agapogu, C. and Agwale S.M (2010). Hepatitis B virus infections in apparently healthy Nigerians: data from pre-vaccination era. J. Infect Dev. Ctries., 4(6):397-400
  5. Akyala, I.A., Onaotle, C. and David I. (2013). Seroprevalence of Hepatitis B and C co-infection among cohort seropositive HIV patients accessing healthcare in Nassarawa State North central, Nigeria. British J. Psychol. Res., 1(1): 15-24.
  6. Babatope, I.O., Inyang, N.J., Imhanrenzor, K. and Agbafwesa, A. (2015). Seroprevalence of Hepatitis (B and C) viruses among apparently healthy Adults in Ekpoma, Edo State, Nigeria. Special Viral Pathogent Journal (SVPJ). 1(1): 15-20.
  7. Bukhari, D.N., Bassi, A.P. and Mangoro Z.M. (2005). Sero-prevalence of Hepatitis B surface antigen among primary school pupils in rural Hausa valley. Borno State, Nigeria. J. Comm. Med Primary Health Care, 17(1): 20-23.
  8. Duwaiu, S.S and Kawo A.H. (2006). Seroprevalence of Hepatitis B surface antigen (HBsAg) among pregnant women attending an urban maternity hospital in Kano State, Nigeria. Nig. J. Microbiol., 20: 705-709.
  9. Duwuring, J.S., Bukhari, D.N., Ajayi, B.B. and Baba M.M. (2012). Prevalence of Hepatitis B and C virus co-infection among students of University of Maiduguri, Nigeria. Arch. Appl. Sci. Rev. 4 (4):1581-1584
  10. Egah, D.Z., Banwat, E.B., Audu, E.S., Iya, D., Mandong, B.M., Awele, A.A. and Gomwalk, N.E. (2007). Hepatitis B surface antigen, Hepatitis C and HIV antibodies in a low risk blood donor group, Nigeria. East Med. Health J., 13: 211-215.
  11. Esan, A.J., Omisakin, C.T., Ojo-Bola, T., Owosemi, M.F., Fasakin, K.A. and Ogunleye, A.A.(2014). Seroprevalence of Hepatitis B and Hepatitis C virus co-infection among pregnant women in Nigeria. Am. J. Biomed. Res., 2(1): 11-15.
  12. Frank, C., Mohammed, M. and Strickland, G. (2002). The role of parental antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355: 887-891.
  13. Ibrahim, I.A. and Pondei, K. (2013). Prevalence of Hepatitis B and C Infection: should gynaecological patients be routinely screened? Int. J. Med. Biomed. Res., 3(1): 45-51.
  14. Imoru, M., Eke, C. and Adegoke, A. (2003). Prevalence of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) among blood donors in Kano state, Nigeria. J. Med. Lab. Sci., 12(1): 59-63.
  15. Jesse, A.O., Babafemi, O.T. and Titilola, S.A. (2008). Prevalence of Hepatitis B and C Seropositivityin a Nigerian cohort of HIV-infected patients. Ann. Hepatol., 7(2): 152–156.
  16. Kaper D.L., Hauser S.L., Long D.L., editors. Harrison's principles of Internal Medicine. NY: McGraw Hill, p1677-1281.
  17. Kolawole, O.M., Wahab, A.A., Adekande, D.A., Sofowora, T. And Okah A. (2012). Seroprevalence of Hepatitis B surface antigenemia its effects on haematological parameters in pregnant women in Osogbo, Nigeria. Virol. J., 9:317
  18. Komas, N.P., Hai-sepon, S., Manirakiu, A., Leal, J., Bere, A. and Faoc, A.L. (2010). The prevalence of Hepatitis B virus markers in a cohort of students in Bangui, Central African Republic. BMC Infect. Dis., 10:226-231.
  19. Kumar, A., Sharma, K.A., Gupta, R.K., Kar, P. and Chakravarti, A. (2007). Prevalence and risk factors for Hepatitis C virus among pregnant women. Ind. J. Med. Res. 126: 211-215.
  20. Madhava, V., Burgess, C. and Drucker, E. (2002). Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect. Dis., 2: 293 – 302.
  21. Martina, N.A., Onitadenma, I.M., Ejike, O.A. and Okorie, O.G. (2014), Detection of Hepatitis-B Surface Antigen (HBsAg) and Hepatitis C Virus (HCV) among Voluntary Blood Donors in Enugu. J. Nat. Sci. Res., 4(16): 79-33.
  22. Mbanya, D., Loulf, D. and Owefli, J. (2010). Sero-prevalence of Hepatitis B surface antigen and clinic elements in a private hospital in Onitsha, South-east. Nig. Med. J., 51(4): 152-154.
  23. Mishra, L. and Seeff, L.B. (1992). Viral hepatitis A through E, Complicating pregnancy. Gastroenterol. Clin. North Am, 21(4): 873-887.
  24. Motta-Castro, A.R.C., Yoshida, C.F.T., Lemos, E.R.S., Oliveira, J.M., Cunha, R.V., Lewis-Ximenez, L.L., Cabello, P.H., Lima, K.M.B. and Martins, R.M.B. (2005). Seroprevalence of Hepatitis B virus infection among Afro-descendant community in Brazil. Memorias do Instituto Osvaldo Cruz; Rio de Janeiro. 98(1):13-17.
  25. Ndong-Atome, G.R., Makuwa, M., Njouom, R., Branger, M., Brun-Vezinet, F., Mahe, A., Rousset, D. and Kazanji, M. (2008). Prevalence of Hepatitis B virus and genetic diversity among pregnant women in Gabon, Central Africa. BMC Infect. Dis., 8(1): 82.
  26. Ojo, O.S., Okade, J.O. and Odesanmi, W.O. (1990). The pathologic basis of chronic liver disease in a tropical population: A biopsy study. Orient. J. Med., 40: 190-195.
  27. Onyekaye, J.A., Fasola, F.A. and Abja, A. (2003). Prevalence of Hepatitis B surface and E antigens, risk factors for viral acquisition and serum transaminase among blood donors in Ibadan, Nigeria. Trop. Gastroenterol, 24:196-197.
  28. Oladeinde, B.H., Omoregie, R. and Oladeinde, O.B. (2013). Sero-prevalence of HBV and HCV infections among pregnant women receiving antenatal care in a traditional birth home in Benin City, Saudi J. Health Sci., 2:113-117.
  29. Oladele, O.O., Adesina, T.B., Omolola, Z.T. and Sunday, T.S. (2013). Prevalence of HBsAg and HCV among blood donors in Osogbo, Osun State, Nigeria. Int. Res. J. Med. Med. Sci. 1(3):68-71.
  30. Pennab, G.R., Yakubu, A., Oyige, O. and Forbi, D. (2010). Prevalence of people among people of a local community in Keffi, Nigeria. Afr. J. Microbiol. Res., 4(4): 274-278.
  31. Pennab, G.R., Osanga, E.T. and Ubam, A. (2011). Seroprevalence of Hepatitis B surface antigen among women attending antenatal clinic in Federal Medical Centre, Keffi, Nigeria. Res. J. Med. Sci., 5(2): 80-87.
  32. Pondei, K. and Ibrahim, I. (2013). The Sero-prevalence of Hepatitis B surface and anti-hepatitis C antibody among women attending antenatal clinic at a tertiary health facility in the Niger Delta of Nigeria. Global Adv. Res. J. Med. Med. Sci. 2(1): 6-12.
  33. Polyak, P. (2006). Innate intracellular defence against HIV and its modulation by HCV gene product. Postgraduate course, Vienna. pp. 30-33.
  34. Royce, R.A., Sena, A., Cates, W. Jr and Cohen, M.S. (1997). Sexual transmission of HIV. N.Engl. J. Med., 336(15): 1072-1078.
  35. Samuel, D., Muller, R. and Alexander, G. (2004). Educational Research, National Hepatitis B virus programme. Infect. Dis. 234: 231-233.
  36. Schiff, E. (2002). Hepatitis Central, Current information on Hepatitis B and C treatment for Medical profession. Uni. Miami. 1-29.
  37. Sheyin, Z., Jatau, E.D., Mamman, A.I, Randawa, A.J and Bigwan, I.E. (2002).Detection of Hepatitis C virus among pregnant women in Kaduna State, Nigeria. Wudpecker, J. Med. Sci., 1(2): 12-15.
  38. Strickland, G.T. (2002). HCV in Developing Countries. Postgrad. Doc. (Africa) 24: 18-20.
  39. Tran TT (2009). Understanding cultural barriers in Hepatitis B virus infection. Cleveland Clin. J. Med. 76(Suppl 3): 10-13.
  40. Tula, M.Y. and Iyoha, O. (2015). A Cross-sectional Study on Sero-prevalence of Hepatitis B Surface Antigen (HBsAg) among Apparently Healthy Students of a Tertiary Institution in North-Eastern Nigeria. Int. J. Trop. Dis. Health, 7 (3): 102-108.
  41. Ugbebor, O., Aigbirior, M., Osazuwa, F., Enabudoso, E. and Zabayo, O. (2011). The prevalence of Hepatitis B and C viral infection among pregnant women. North Am. J. Med. Sci, 3(5): 238-241.
  42. Uneke, C.J., Ogbu, P.U.E., Anyanwu, G.I., Njoku, M.O. and Idoko, J.H. (2005). Prevalence of Hepatitis B surface antigen and human immuno deficiency virus (HIV) infection among pregnant women in Jos, Nigeria. Afr. Health Sci. 5: 58-59
  43. Wejstal, R., Widell, A., Mansson, S. and Norkrans, G. (1992). Mother-to-infant Transmission of Hepatitis C Virus. Ann. Internal Med. 117 (11): 887-890
  44. World Health Organization (1999) Hepatitis. Antwerp, Belgium 1999 10.1046/j.1365-2893.6120139.
  45. World Health Organization (2000). Hepatitis C. Fact Sheet No 204. Geneva:
  46. Yakassai, I.A., Ayuba, R., Abubakar, I.S. and Ibrahim, S.A. (2012). Seroprevalence of Hepatitis B viral infection and its risk factors among pregnant women attending antenatal clinic at Aminio Kano Teaching Hospital Kano, Nigeria. J. Basic Clin. Reprod. Sci., 1: 49-55.
How to Cite

Tula, M. Y., O., I., E.A., O., A., M., P.O., I., & A,N., O. (2018). Seroprevalence of Hepatitis B surface antigen (HBsAg) and: Hepatitis C virus (HCV) co-infection among Apparently Healthy Students of a Tertiary Institution in North-eastern Nigeria. Nigerian Journal of Microbiology, 32(1), 4290-4296. https://doi.org/10.67614/njm.2018.g284hwi9

M. Y. Tula, I. O., O. E.A., M. A., I. P.O., and O. A,N., "Seroprevalence of Hepatitis B surface antigen (HBsAg) and: Hepatitis C virus (HCV) co-infection among Apparently Healthy Students of a Tertiary Institution in North-eastern Nigeria," Nigerian Journal of Microbiology, vol. 32, no. 1, pp. 4290-4296, June 2018. doi: 10.67614/njm.2018.g284hwi9

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles